S&P 500   2,995.68 (+1.00%)
DOW   27,024.80 (+0.89%)
QQQ   193.52 (+1.27%)
AAPL   235.32 (-0.23%)
FB   188.89 (+3.06%)
MSFT   141.58 (+1.45%)
GOOGL   1,242.24 (+2.01%)
AMZN   1,767.38 (+1.78%)
CGC   20.10 (+6.57%)
NVDA   196.37 (+5.28%)
MU   46.46 (+3.54%)
BABA   175.29 (+2.41%)
GE   8.89 (+1.95%)
TSLA   257.89 (+0.36%)
AMD   30.72 (+0.62%)
T   37.90 (+1.15%)
F   9.07 (+2.83%)
ACB   3.76 (+7.12%)
PRI   123.67 (+1.81%)
NFLX   284.25 (-0.45%)
BAC   29.73 (+2.02%)
GILD   65.30 (+1.22%)
DIS   129.76 (+0.05%)
S&P 500   2,995.68 (+1.00%)
DOW   27,024.80 (+0.89%)
QQQ   193.52 (+1.27%)
AAPL   235.32 (-0.23%)
FB   188.89 (+3.06%)
MSFT   141.58 (+1.45%)
GOOGL   1,242.24 (+2.01%)
AMZN   1,767.38 (+1.78%)
CGC   20.10 (+6.57%)
NVDA   196.37 (+5.28%)
MU   46.46 (+3.54%)
BABA   175.29 (+2.41%)
GE   8.89 (+1.95%)
TSLA   257.89 (+0.36%)
AMD   30.72 (+0.62%)
T   37.90 (+1.15%)
F   9.07 (+2.83%)
ACB   3.76 (+7.12%)
PRI   123.67 (+1.81%)
NFLX   284.25 (-0.45%)
BAC   29.73 (+2.02%)
GILD   65.30 (+1.22%)
DIS   129.76 (+0.05%)
Log in

Oxford Biodynamics Stock Price, News & Analysis (LON:OBD)

GBX 94.75
+5.75 (+6.46 %)
(As of 10/15/2019 04:00 PM ET)
Today's Range
86.50
Now: GBX 94.75
95
50-Day Range
83.25
MA: GBX 90.45
100
52-Week Range
75.11
Now: GBX 94.75
226
Volume50,001 shs
Average Volume67,675 shs
Market Capitalization£87.70 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use within the pharmaceutical and biotechnology industry primarily in the United Kingdom and Malaysia. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures. It has collaboration agreements with Holos Life Sciences Pte. Ltd. to develop non-invasive epigenetic biomarkers associated with sports-related concussions; and Casa Sollievo della Sofferenza to identify EpiSwitch biomarkers for the blood-based diagnosis of Autism Spectrum Disorder. The company was founded in 2007 and is headquartered in Oxford, the United Kingdom.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1865-518910

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£1.29 million
Cash FlowGBX 19.37 per share
Book ValueGBX 20.50 per share

Profitability

Miscellaneous

Employees31
Market Cap£87.70 million
Next Earnings DateN/A
OptionableNot Optionable

Receive OBD News and Ratings via Email

Sign-up to receive the latest news and ratings for OBD and its competitors with MarketBeat's FREE daily newsletter.


Oxford Biodynamics (LON:OBD) Frequently Asked Questions

What is Oxford Biodynamics' stock symbol?

Oxford Biodynamics trades on the London Stock Exchange (LON) under the ticker symbol "OBD."

How were Oxford Biodynamics' earnings last quarter?

Oxford Biodynamics PLC (LON:OBD) issued its earnings results on Tuesday, December, 11th. The biotechnology company reported ($2.20) EPS for the quarter. View Oxford Biodynamics' Earnings History.

Has Oxford Biodynamics been receiving favorable news coverage?

Press coverage about OBD stock has trended neutral this week, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Oxford Biodynamics earned a news sentiment score of 0.4 on InfoTrie's scale. They also gave media headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Oxford Biodynamics.

Who are some of Oxford Biodynamics' key competitors?

What other stocks do shareholders of Oxford Biodynamics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oxford Biodynamics investors own include Oxford BioMedica (OXB), GALAPAGOS NV/S (GLPG), Fate Therapeutics (FATE), Casey's General Stores (CASY), AXT (AXTI), American Woodmark (AMWD), Savannah Resources (SAV), Nanoco Group (NANO), Biffa (BIFF) and Valdor Technology International (VTI).

Who are Oxford Biodynamics' key executives?

Oxford Biodynamics' management team includes the folowing people:
  • Mr. Christian Gurth Hoyer Millar, CEO & Director (Age 60)
  • Mr. Paul Leslie Stockdale, CFO & Director (Age 44)
  • Dr. Alexandre Akoulitchev, Chief Scientific Officer & Director (Age 57)
  • Mr. Glen A. Ferguson, Pres & Sr. VP of Group's Bus. Devel. of USA
  • Dr. Aroul Ramadass Ph.D.(CANTAB), PDF (OXON), FCPS, FRAS, Chief Technology Officer

How do I buy shares of Oxford Biodynamics?

Shares of OBD and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Oxford Biodynamics' stock price today?

One share of OBD stock can currently be purchased for approximately GBX 94.75.

How big of a company is Oxford Biodynamics?

Oxford Biodynamics has a market capitalization of £87.70 million and generates £1.29 million in revenue each year. Oxford Biodynamics employs 31 workers across the globe.View Additional Information About Oxford Biodynamics.

What is Oxford Biodynamics' official website?

The official website for Oxford Biodynamics is http://www.oxfordbiodynamics.com/.

How can I contact Oxford Biodynamics?

Oxford Biodynamics' mailing address is 26 Beaumont Street, OXFORD, OX1 2NP, United Kingdom. The biotechnology company can be reached via phone at +44-1865-518910.


MarketBeat Community Rating for Oxford Biodynamics (LON OBD)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  92 (Vote Outperform)
Underperform Votes:  97 (Vote Underperform)
Total Votes:  189
MarketBeat's community ratings are surveys of what our community members think about Oxford Biodynamics and other stocks. Vote "Outperform" if you believe OBD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OBD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel